Summary
- Current Price
- As of today, AXSM price is $156.35, down -4.82% on
- Current Price All-Time High
- AXSM price is currently -18.36% below its historical high of $191.50 set on
- Market Cap
- AXSM current market cap is $8B, up +32.73% over the past 365 days
- PE Ratio
- AXSM PE ratio is unknown
- Revenue
- AXSM current annual revenue is $638.50M, up +65.55% year-over-year
- Next Earnings
- The next earnings release for AXSM is on
Profile
| Metric | Value |
|---|---|
| Full Name | Axsome Therapeutics, Inc. |
| Ticker | NASDAQ: AXSM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | axsome.com |
| Employees | 712 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $156.35 | |
| Price, 1D Change | -4.82% | |
| $8B | ||
| - | ||
| - | ||
| 0.59 | ||
| $638M | ||
| Revenue, 1Y Change | +65.55% | |
| -$3.68 | ||
| EPS, 1Y Change | +38.57% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.68 | ||
| EPS Estimate | N/A | -$1.04 |
| EPS Est. Change | N/A | +71.70% |
| $638.50M | ||
| Revenue Estimate | N/A | $988.00M |
| Revenue Est. Change | N/A | +54.74% |
| Current Price | $156.35 | |
| Price Target | - | $222.00 |
| Price Tgt. Change | - | +41.99% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$5.15 | -$5.99 | -16.40% | |
| -$3.87 | -$3.68 | +4.84% | |
| -$1.04 | N/A | +71.70% | |
| $5.76 | N/A | +256.50% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $385.06M | $385.69M | +0.16% | |
| $635.84M | $638.50M | +0.42% | |
| $988.00M | N/A | +54.74% | |
| $1.55B | N/A | +142.10% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $156.35 | |
| $138.48 | ||
| SMA 200 vs Price | -11.43% | |
| $172.98 | ||
| SMA 50 vs Price | +10.64% | |
| 0.59 | ||
| $5.48 | ||
| 40.25 | ||
| 34.38% | ||
| 40.61% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $638.50M | ||
| -$3.68 | ||
| $581.95M | ||
| 91.14% | ||
| -$169.24M | ||
| -26.51% | ||
| -$183.17M | ||
| -28.69% | ||
| -$160.17M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 2.47 | ||
| 1.55 | ||
| 1.48 | ||
| - | ||
| 4 | ||
| 5.69 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 12.34 | ||
| 89.27 | ||
| -48.52 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $88.29M | ||
| $322.93M | ||
| $689.81M | ||
| $588.99M | ||
| $601.51M | ||
| $378.84M | ||
| $218.11M | ||
| $72.98M | ||
| $65.54M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $821.67M | ||
| $751.19M | ||
| $56.54M | ||
| $0.00 | ||
| $9.06M | ||
| $0.00 | ||
| -$530.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$93.41M | ||
| -$480.00K | ||
| $101.47M | ||
| $480.00K | ||
| -$93.89M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Guggenheim | → | |
| Wolfe Research | ||
| Wells Fargo | → | |
| UBS | → | |
| RBC Capital | → | |
| Guggenheim | → | |
| Needham | → | |
| Jefferies | → | |
| Leerink Partners | → | |
| RBC Capital | → |
Analyst sentiment
Institutional ownership
Screeners with AXSM
FAQ
What is the ticker symbol for Axsome Therapeutics, Inc.?
The ticker symbol for Axsome Therapeutics, Inc. is NASDAQ:AXSM
Does Axsome Therapeutics, Inc. pay dividends?
No, Axsome Therapeutics, Inc. does not pay dividends
What sector is Axsome Therapeutics, Inc. in?
Axsome Therapeutics, Inc. is in the Healthcare sector
What industry is Axsome Therapeutics, Inc. in?
Axsome Therapeutics, Inc. is in the Biotechnology industry
What country is Axsome Therapeutics, Inc. based in?
Axsome Therapeutics, Inc. is headquartered in United States
When did Axsome Therapeutics, Inc. go public?
Axsome Therapeutics, Inc. initial public offering (IPO) was on November 19, 2015
Is Axsome Therapeutics, Inc. in the S&P 500?
No, Axsome Therapeutics, Inc. is not included in the S&P 500 index
Is Axsome Therapeutics, Inc. in the NASDAQ 100?
No, Axsome Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Axsome Therapeutics, Inc. in the Dow Jones?
No, Axsome Therapeutics, Inc. is not included in the Dow Jones index
When was Axsome Therapeutics, Inc. last earnings report?
Axsome Therapeutics, Inc.'s most recent earnings report was on February 23, 2026
When does Axsome Therapeutics, Inc. report earnings?
The next expected earnings date for Axsome Therapeutics, Inc. is May 4, 2026
Data Sources & References
- AXSM Official Website www.axsome.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1579428/000119312526064267/0001193125-26-064267-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1579428/000119312526064267/0001193125-26-064267-index.htm
- AXSM Profile on Yahoo Finance finance.yahoo.com/quote/AXSM
- AXSM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/axsm